drugset / Trial / NCT03970330
Low-Dose Naltrexone in Combination With Standard Treatment in Women With Endometriosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if the addition of Low Dose Naltrexone to standard endometriosis treatments will improve patient reported endometriosis associated pain.
Timeline
- Start
- 2020-01-16
- Primary completion
- 2021-06-21
- Completion
- 2021-06-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naltrexone | Small molecule | 4.5 mg | Oral |
| Background | Norethindrone | Unknown | 5 mg | Oral |
| Background | Norethindrone | Unknown | 15 mg | Oral |